End-User Insights: Hospitals, Academic Labs, and Cancer Centers Drive NGS Implementation
The global clinical oncology next generation sequencing (NGS) market stood at USD 477.16 million in 2024, with expectations of robust expansion at a CAGR of 16.58% from 2025 to 2034. This growth is being catalyzed by key countries such as the United States, China, Germany, and Japan, each contributing significantly to global revenue through strategic R&D investments, local manufacturing...
0 Comments 0 Shares 47 Views 0 Reviews
Watachat https://watachat.com